USANA HEALTH SCIENCES INC
Company Stats
- Market Cap
- $267.4M
- as of Sep 30, 2026
- Shares Outstanding
- 18.5M
- Free Float
- 50.5%
Income Statement
- Revenue
- $925.3M
- Operating Income
- $37.4M
- Net Income
- $10.8M
- EBITDA
- $70.0M
- Non-cash Impairment
- $6.5M
Cash Flow
- Free Cash Flow
- $8.5M
- FCF Yield
- 3.2%
- Owner FCF Yield
- -2.0%
Balance Sheet
- Cash & Equivalents
- $158.4M
Returns & Capital
- Share Repurchases
- $27.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2026 | $925.3M | $8.5M | 0.9% |
| FY2024 | $854.5M | $50.9M | 6.0% |
| FY2023 | $921.0M | $56.1M | 6.1% |
| FY2022 | $998.6M | $93.5M | 9.4% |
| FY2022 | $1.2B | $108.5M | 9.1% |
Annual filing data through FY ended January 3, 2026; shares and float as of October 25, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back